Evidence map›Paper›PMID 33168072›Full record

ArticleGenome medicine2020

Genomics in the era of COVID-19: ethical implications for clinical practice and public health.

Gail Geller, Priya Duggal, Chloe L Thio, Debra Mathews, Jeffrey P Kahn, Lisa L Maragakis, Brian T Garibaldi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gail GellerBerman Institute of Bioethics, Johns Hopkins University, Deering Hall, Room 202, 1809 Ashland Ave., Baltimore, MD, 21205, USA. ggeller@jhu.edu.ORCID 0000-0003-4856-1942
Priya DuggalJohns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD, 21205, USA.
Chloe L ThioJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Debra MathewsBerman Institute of Bioethics, Johns Hopkins University, Deering Hall, Room 202, 1809 Ashland Ave., Baltimore, MD, 21205, USA.
Jeffrey P KahnBerman Institute of Bioethics, Johns Hopkins University, Deering Hall, Room 202, 1809 Ashland Ave., Baltimore, MD, 21205, USA.
Lisa L MaragakisJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Brian T GaribaldiJohns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Ethical, Legal and Social Issues for Precision Medicine and Infectious DiseaseRM1HG009038 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI GELLER, GAIL, KAHN, JEFFREY P. · 2016 to 2020
$4.8M
NHGRI NIH HHS RM1 HG009038NHGRI NIH HHS RM1HG009038
6 · The paper itself

Abstract

Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications-both potential benefits and harms-of genomics for clinical practice and public health in the era of COVID-19.

Indexed as

BetacoronavirusClinical Decision-MakingCoronavirus InfectionsCOVID-19Genetic Predisposition to DiseaseGenetic TestingGenomicsHumansPandemicsPneumonia, ViralPublic HealthSARS-CoV-2COVID-19EthicsHost genomics

Identifiers

PMID33168072
PMCPMC7649891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.